has been cited by the following article(s):
|
[1]
|
A light-responsive, self-immolative linker for controlled drug delivery via peptide-and protein-drug conjugates
|
|
2019 |
|
|
|
|
[2]
|
Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer
|
|
Drug Delivery,
2018 |
|
|
|
|
[3]
|
The Use of Antibody as Drug Carrier in Cancer Chemotherapy
|
|
Sokoto Journal of Medical Laboratory Science,
2017 |
|
|
|
|
[4]
|
Augmenting the cytotoxicity of oleic acid-protein complexes: Potential of target-specific antibodies
|
|
Biochimie,
2017 |
|
|
|
|
[5]
|
In vitro Anticancer Activity of Doxorubicin-Loading Pectin Nanoparticles
|
|
2016 |
|
|
|
|
[6]
|
Exploiting Nanocarriers for Combination Cancer Therapy
|
|
Intracellular Delivery III,
2016 |
|
|
|
|
[7]
|
Targeted delivery of anti-cancer drugs by MS2 virus-like particles
|
|
2015 |
|
|
|
|
[8]
|
Doxorubicin Affects Expression of Proteins of Neuronal Pathways in MCF-7 Breast Cancer Cells
|
|
Cancer Genomics-Proteomics,
2015 |
|
|
|
|
[9]
|
Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core–shell drug-carrier based on heparin modified poly (L-lactide) …
|
|
Journal of Biomedical Nanotechnology,
2014 |
|
|
|
|
[10]
|
Enhanced 4T1 Breast Carcinoma Anticancer Activity by Co-Delivery of Doxorubicin and Curcumin with Core–Shell Drug-Carrier Based on Heparin Modified Poly (L-lactide) Grafted Polyethylenimine Cationic Nanoparticles
|
|
Journal of biomedical …,
2014 |
|
|
|
|
[11]
|
Synthesis, characterization and biological activities of curcumin nanospheres
|
|
Journal of biomedical nanotechnology,
2014 |
|
|
|
|
[1]
|
Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects
ASSAY and Drug Development Technologies,
2023
DOI:10.1089/adt.2022.102
|
|
|
|
|
[2]
|
A light-responsive, self-immolative linker for controlled drug delivery via peptide- and protein-drug conjugates
Chemical Science,
2019
DOI:10.1039/C9SC03016F
|
|
|
|
|
[3]
|
Cytotoxic Payloads for Antibody – Drug Conjugates
2019
DOI:10.1039/9781788012898-00137
|
|
|
|
|
[4]
|
Cytotoxic Payloads for Antibody – Drug Conjugates
2019
DOI:10.1039/9781788012898-00137
|
|
|
|
|
[5]
|
Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer
Drug Delivery,
2018
DOI:10.1080/10717544.2018.1435746
|
|
|
|
|
[6]
|
Augmenting the cytotoxicity of oleic acid-protein complexes: Potential of target-specific antibodies
Biochimie,
2017
DOI:10.1016/j.biochi.2017.03.013
|
|
|
|
|
[7]
|
Intracellular Delivery III
Fundamental Biomedical Technologies,
2016
DOI:10.1007/978-3-319-43525-1_16
|
|
|
|